As shown in Fig. 1, NLRP3 and AIM2 mRNA levels in patients with aMCI or AD were higher than those in controls (Fig. 2a, b), but NLRP1 and NLRC4 expression did not differ among the groups (Fig. 2c, d). This evidence concerns the gene NLRP3 and Alzheimer disease.